2017
DOI: 10.2214/ajr.17.18100
|View full text |Cite
|
Sign up to set email alerts
|

Primary Hepatic Neoplasms of Vascular Origin: Key Imaging Features and Differential Diagnoses With Radiology-Pathology Correlation

Abstract: Familiarity with the spectrum of benign, malignant-potential and malignant vascular neoplasms, and nonneoplastic mimickers allows consideration in the differential diagnosis of enhancing hepatic masses. Understanding relevant pathologic features facilitates recognition of key imaging features, specifically dynamic contrast enhancement patterns on CT and MRI, which provide a useful classification system.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 48 publications
0
12
0
Order By: Relevance
“…In contrast, the appearance of a hepatic PEComa on CT or MRI is well defined with early enhancement in the arterial phase and nonuniform enhancement in the venous and delayed phases[ 14 ]. Lesions with delayed washout may mimic HCC[ 15 ]. Consistent with the study results, hepatic PEComa should still be considered whenever a blotchy vascular pattern of the tumor is noted, if there is no evidence of hemorrhage in the tumor, if there is no abnormality in the background parenchyma, when no hepatitis virus markers have been detected, and when liver function tests and tumor markers (AFP, CEA) are normal[ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, the appearance of a hepatic PEComa on CT or MRI is well defined with early enhancement in the arterial phase and nonuniform enhancement in the venous and delayed phases[ 14 ]. Lesions with delayed washout may mimic HCC[ 15 ]. Consistent with the study results, hepatic PEComa should still be considered whenever a blotchy vascular pattern of the tumor is noted, if there is no evidence of hemorrhage in the tumor, if there is no abnormality in the background parenchyma, when no hepatitis virus markers have been detected, and when liver function tests and tumor markers (AFP, CEA) are normal[ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Rather than presenting with single, discrete VMs, liver involvement in HHT is typically diffuse and heterogeneous. Histologically, VMs result in both microscopic changes, such as ectatic sinusoids, and macroscopic vascular anomalies [2]. Diffusely distributed hepatic VMs are relatively characteristic of HHT and unusual in other vascular disorders; therefore, diffuse involvement with VMs should always raise suspicion for underlying HHT [8].…”
Section: Hepatic Vascular Malformationsmentioning
confidence: 99%
“…Hereditary hemorrhagic telangiectasia (HHT), also called Osler-Weber-Rendu, is an autosomal dominant disorder characterized by arteriovenous malformations (AVMs) throughout the body [1]. The hallmark lesion of HHT is the telangiectasia, a direct connection between the arteriole and venule, bypassing the capillary bed [2]. HHT most commonly involves mutations of two genes: endoglin (ENG, on chromosome 9, HHT1) or activin A receptor type II-like 1 (ACVRL1/ALK1, on chromosome 12, HHT2).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…HHT can involve specific and nonspecific liver lesions in forms ranging from small telangiectasia to large arteriovenous malformations. The hallmark lesion is represented by telangiectasia, a direct connection between the arteriole and venule which bypasses the capillary bed [ 7 ]. The different severities of liver vascular malformation explain the high variability of clinical symptoms [ 6 ].…”
Section: Introductionmentioning
confidence: 99%